Neurologic risk assessment, monitoring and outcome in cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 6, 1999, Pages 736-743

  Arrowsmith, Joseph E ^a   Grocott, Hilary P ^a   Newman, Mark F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac surgery; Risk factors; Stroke

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APROTININ;

ANTICOAGULANT THERAPY; BRAIN EMBOLISM; DOPPLER ECHOGRAPHY; ELECTROENCEPHALOGRAM; GENETIC PREDISPOSITION; HEART SURGERY; HUMAN; INFRARED SPECTROSCOPY; NEUROLOGICAL COMPLICATION; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STROKE;

EID: 0033462138     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90132-5     Document Type: Review

References (98)

1. Warner CD, Weintraub WS, Craver JM, et al: Effect of cardiac surgery patient characteristics on patient outcomes from 1981 through 1995. Circulation 96:1575-1579, 1997
2. Roach GW, Kanchuger M, Mora Mangano C, et al: Adverse cerebral outcomes after coronary artery bypass surgery. N Engl J Med 335:1857-1863, 1996
3. McKhann GM, Goldsborough MA, Borowicz LM Jr, et al: Predictors of stroke risk in coronary artery bypass patients. Ann Thorac Surg 63:516-521, 1997
4. Gardner TJ, Homeffer PJ, Manolio TA, et al: Stroke following coronary artery bypass grafting: A ten-year study. Ann Thorac Surg 40:574-581, 1985
5. Tuman KJ, McCarthy RJ, Najafi H, Ivankovich AD: Differential effects of advanced age on neurologic and cardiac risks of coronary artery operations. J Thorac Cardiovasc Surg 104:1510-1517, 1992
6. Newman S: The incidence and nature of neuropsychological morbidity following cardiac surgery. Perfusion 4:93-100, 1989
7. Townes BD, Bashein G, Hornbein TF, et al: Neurobehavioral outcomes in cardiac operations: A prospective controlled study. J Thorac Cardiovasc Surg 98:774-782, 1989
8. Newman MF, Croughwell ND, Blumenthal JA, et al: Effect of aging on cerebral autoregulation during cardiopulmonary bypass: Association with postoperative cognitive dysfunction. Circulation 90: 11243-249, 1994
9. Alberts MJ, Graffagnino C, McClenny C, et al: ApoE genotype and survival from intracerebral haemorrhage. Lancet 346:575, 1995
10. Tang MX, Maestre G, Tsai WY, et al: Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease. Ann N Y Acad Sci 802:6-15, 1996
11. Sorbi S, Nacmias B, Piacentini S: Apolipoprotein E genotypes and outcome after post-traumatic coma. Neurology 46:A307, 1996
12. Slooter AJ, Tang MX, van Duijn CM, et al: Apolipoprotein E epsilon4 and the risk of dementia with stroke: A population-based investigation. JAMA 277:818-821, 1997
13. Jordan BD, Relkin NR, Ravdin LD, et al: Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA 278:136-140, 1997
14. Tardiff BE, Newman MF, Saunders AM, et al: Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg 64:715-720, 1997
15. Laskowitz DT, Sheng H, Bart RD, et al: Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J Cereb Blood Flow Metab 17:753-758, 1997
16. Sheng H, Laskowitz DT, Bennett E, et al: Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J Cereb Blood Flow Metab 18:361-366, 1998
17. Laskowitz DT, Goel S, Bennett ER, Matthew WD: Apolipoprotein E suppresses glial cell secretion of TNF alpha. J Neuroimmunol 76:70-74, 1997
18. Laskowitz DT, Matthew WD, Bennett ER, et al: Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. Neuroreport 9:615-618, 1998
19. Moody DM, Bell MA, Challa VR, et al: Brain microemboli during cardiac surgery or aortography. Ann Neurol 28:477-486, 1990
20. Blauth C, Arnold J, Kohner EM, Taylor KM: Retinal microembolism during cardiopulmonary bypass demonstrated by fluorescein angiography. Lancet 2:837-839, 1986
21. Padayachee TS, Parsons S, Theobold R, et al: The detection of microemboli in the middle cerebral artery during cardiopulmonary bypass: A transcranial Doppler ultrasound investigation using membrane and bubble oxygenators. Ann Thorac Surg 44:298-302, 1987
22. Pugsley W: The use of Doppler ultrasound in the assessment of microemboli during cardiac surgery. Perfusion 4:115-122, 1989
23. Stump DA, Rogers AT, Hammon JW, Newman SP: Cerebral emboli and cognitive outcome after cardiac surgery. J Cardiothorac Vasc Anesth 10:113-118, 1996
24. Pugsley W, Klinger L, Paschalis C, et al: The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 25:1393-1399, 1994
25. Clark RE, Brillman J, Davis DA, et al: Microemboli during coronary artery bypass grafting. J Thorac Cardiovasc Surg 109:249-258, 1995
26. Blauth CI, Smith PL, Arnold JV, et al: Influence of oxygenator type on the prevalence and extent of microembolic retinal ischemia during cardiopulmonary bypass: Assessment by digital image analysis. J Thorac Cardiovasc Surg 99:61-69, 1990
27. Padayachee TS, Parsons S, Theobold R, et al: The effect of arterial filtration on reduction of gaseous microemboli in the middle cerebral artery during cardiopulmonary bypass. Ann Thorac Surg 45:647-649, 1988
28. Brooker RF, Brown WR, Moody DM, et al: Cardiotomy suction: A major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg 65:1651-1655, 1998
29. Mottaghy K, Oedekoven B, Poppel K, et al: Heparin-coated versus non-coated surfaces for extracorporeal circulation. Int J Artif Organs 14:721-728, 1991
30. Jones DR, Hill RC, Vasilakis A, et al: Safe use of heparin-coated bypass circuits incorporating a pump-oxygenator. Ann Thorac Surg 57:815-818, 1994
31. Ovrum E, Mollnes TE, Fosse E, et al: Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg 110:1623-1632, 1995
32. Dewanjee MK, Rowland SM, Kapadvanjwala M, et al: The dynamics of platelet thrombus formation rate, thrombus retention time, and rate of embolization on a control and heparin bonded polyurethane angio-catheter. ASAIO Trans 36:M745-749, 1990
33. Ritter EF, Kim YB, Reischl HP, et al: Heparin coating of vascular prostheses reduces thromboemboli. Surgery 122:888-892, 1997
34. Aldea GS, Doursounian M, O'Gara P, et al: Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: A prospective, randomized study. Ann Thorac Surg 62:410-417, 1996
35. Aldea GS, O'Gara P, Shapira OM, et al: Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg 65:425-433, 1998
36. Newman MF, Croughwell ND, White WD, et al: Effect of perfusion pressure on cerebral blood flow during normothermic cardiopulmonary bypass. Circulation 94:11353-357, 1996
37. Grubhofer G, Lassnigg AM, Schneider B, et al: Jugular venous bulb oxygen saturation depends on blood pressure during cardiopulmonary bypass. Ann Thorac Surg 65:653-657, 1998
38. Cartwright CR, Mora Mangano C: Con: During cardiopulmonary bypass for elective coronary artery bypass grafting, perfusion pressure should not routinely be greater than 70 mmHg. J Cardiothorac Vasc Anesth 12:361-364, 1998
39. Hartman G: Pro: During cardiopulmonary bypass for elective coronary artery bypass grafting, perfusion pressure should routinely be greater than 70 mmHg. J Cardiothorac Vasc Anesth 12:358-360, 1998
40. Gold JP, Charlson ME, Williams-Russo P, et al: Improvement of outcomes after coronary artery bypass: A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 110:1302-1311, 1995
41. Hartman GS, Yao FSF, Bruefach M, et al: Severity of aortic atheromatous disease diagnosed by transesophageal echocardiography predicts stroke and other outcomes associated with coronary artery surgery: A prospective study. Anesth Analg 83:701-708, 1996
42. Govier AV, Reves JG, McKay RD, et al: Factors and their influence on regional cerebral blood flow during nonpulsatile cardiopulmonary bypass. Ann Thorac Surg 38:592-600, 1984
43. Rogers AT, Stump DA, Gravlee GP, et al: Response to cerebral blood flow to phenylephrine infusion during hypothermic cardiopulmonary bypass. Anesthesiology 69:547-551, 1988
44. Soma Y, Hirotani T, Yozu R, et al: A clinical study of cerebral circulation during extracorporeal circulation. J Thorac Cardiovasc Surg 97:187-193, 1989
45. Rogers AT, Prough DS, Roy RC, et al: Cerebrovascular and cerebral metabolic effects of alterations in perfusion flow rate during hypothermic cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 103:363-368, 1992
46. Schwartz AE, Sandhu AA, Kaplon RJ, et al: Cerebral blood flow is determined by arterial pressure and not cardiopulmonary bypass flow rate. Ann Thorac Surg 60:165-169, 1995
47. Grocott HP, Newman MF, Croughwell ND, et al: Continuous jugular venous versus nasopharyngeal temperature monitoring during hypothermic cardiopulmonary bypass for cardiac surgery. J Clin Anesth 9:312-316, 1997
48. Croughwell ND, Frasco P, Blumenthal JA, et al: Warming during cardiopulmonary bypass is associated with jugular bulb desaturation. Ann Thorac Surg 53:827-832, 1992
49. Croughwell ND, Newman MF, Blumenthal JA, et al: Jugular bulb saturation and cognitive dysfunction after cardiopulmonary bypass. Ann Thorac Surg 58:1702-1708, 1994
50. Mora CT, Henson MB, Weintraub WS, et al: The effect of temperature management during cardiopulmonary bypass on neurologic and neuropsychologic outcomes in patients undergoing coronary revascularization. J Thorac Cardiovasc Surg 112:514-522, 1996
51. Singh AK, Feng WC, Bert AA, Rotenberg FA: Warm body, cold heart: Myocardial revascularization in 2383 consecutive patients. J Cardiovasc Surg (Torino) 34:415-421, 1993
52. Warm Heart Investigators: Randomised trial of normothermic versus hypothermic coronary bypass surgery. Lancet 343:559-563, 1994
53. McLean RF, Wong BI, Naylor CD, et al: Cardiopulmonary bypass, temperature, and central nervous system dysfunction. Circulation 90:11250-255, 1994
54. Singh AK, Bert AA, Feng WC, Rotenberg FA: Stroke during coronary artery bypass grafting using hypothermic versus normothermic perfusion. Ann Thorac Surg 59:84-89, 1995
55. Regragui I, Birdi I, Izzat MB, et al: The effects of cardiopulmonary bypass temperature on neuropsychologic outcome after coronary artery operations: A prospective randomized trial. J Thorac Cardiovasc Surg 112:1036-1045, 1996
56. Nevin M, Colchester AC, Adams S, Pepper JR: Evidence for involvement of hypocapnia and hypoperfusion in aetiology of neurological deficit after cardiopulmonary bypass. Lancet 2:1493-1495, 1987
57. Stephan H, Weyland A, Kazmaier S, et al: Acid-base management during hypothermic cardiopulmonary bypass does not affect cerebral metabolism but does affect blood flow and neurological outcome. Br J Anaesth 69:51-57, 1992
58. Venn GE, Patel RL, Chambers DJ: Cardiopulmonary bypass: Perioperative cerebral blood flow and postoperative cognitive deficit. Ann Thorac Surg 59:1331-1335, 1995
59. Croughwell N, Lyth M, Quill TJ, et al: Diabetic patients have abnormal cerebral autoregulation during cardiopulmonary bypass. Circulation 82:IV407-412, 1990
60. Nakai H, Yamamoto YL, Diksic M, et al: Triple-tracer autoradiography demonstrates effects of hyperglycemia on cerebral blood flow, pH, and glucose utilization in cerebral ischemia of rats. Stroke 19:764-772, 1988
61. Li PA, Kristian T, Shamloo M, Siesjö BK: Effects of preischemic hyperglycemia on brain damage incurred by rats subjected to 2.5 or 5 minutes of forebrain ischemia. Stroke 27:1592-1602, 1996
62. Metz S, Keats AS: Benefits of a glucose-containing priming solution for cardiopulmonary bypass. Anesth Analg 72:428-434, 1991
63. Metz S: Pro: Glucose priming solutions should be used for cardiopulmonary bypass. J Cardiothorac Vasc Anesth 9:603-604, 1995
64. Chien S, Usami S, Dellenback J, Magazinovic V: Blood rheology after hemorrhage and endotoxin. Adv Exp Med Biol 33:75-93, 1972
65. Fang WC, Helm RE, Krieger KH, et al: Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 96:11194-199, 1997
66. Cook DJ, Orszulak TA, Daly RC, MacVeigh I: Minimum hematocrit for normothermic cardiopulmonary bypass in dogs. Circulation 96:11200-204, 1997
67. Newman MF, Wolman R, Kanchuger M, et al: Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Circulation 94:1174-80, 1996
68. Naunheim KS, Fiore AC, Wadley JJ, et al: The changing profile of the patient undergoing coronary artery bypass surgery. J Am Coll Cardiol 11:494-498, 1988
69. Lynn GM, Stefanko K, Reed JF, et al: Risk factors for stroke after coronary artery bypass. J Thorac Cardiovasc Surg 104:1518-1523, 1992
70. Frye RL, Kronmal R, Schaff HV, et al: Stroke in coronary artery bypass graft surgery: An analysis of the CASS experience. The participants in the Coronary Artery Surgery Study. Int J Cardiol 36:213-221, 1992
71. Ricotta JJ, Faggioli GL, Castilone A, Hassett JM: Risk factors for stroke after cardiac surgery: Buffalo Cardiac-Cerebral Study Group. J Vasc Surg 21:359-363, 1995
72. Rao V, Christakis GT, Weisel RD, et al: Risk factors for stroke following coronary bypass surgery. J Cardiac Surg 10:468-474, 1995
73. Hartman GS, Peterson J, Konstadt SN, et al: High reproducibility in the interpretation of intraoperative transesophageal echocardiographic evaluation of aortic atheromatous disease. Anesth Analg 82:539-543, 1996
74. Barbut D, Lo YW, Hartman GS, et al: Aortic atheroma is related to outcome but not numbers of emboli during coronary bypass. Ann Thorac Surg 64:454-459, 1997
75. Marschall K, Kanchuger M, Kessler K, et al: Superiority of transesophageal echocardiography in detecting aortic arch atheromatous disease: Identification of patients at increased risk of stroke during cardiac surgery. J Cardiothorac Vasc Anesth 8:5-13, 1994
76. Dávila-Román VG, Phillips KJ, Daily BB, et al: Intraoperative transesophageal echocardiography and epiaortic ultrasound for assessment of atherosclerosis of the thoracic aorta. J Am Coll Cardiol 28:942-947, 1996
77. Ratnoff OD: Epsilon aminocaproic acid - a dangerous weapon. N Engl J Med 280:1124-1125, 1969
78. Stewart DG: EACA and intravascular coagulation. N Engl J Med 281:1247, 1969
79. Bohrer H, Fleischer F, Lang J, Vahl C: Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin. J Cardiothorac Anesth 4:222-225, 1990
80. Dentz ME, Slaughter TF, Mark JB: Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid. Anesthesiology 82:583-586, 1995
81. Cosgrove DM, Heric B, Lytle BW, et al: Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study. Ann Thorac Surg 54:1031-1036, 1992
82. Kamiya T, Katayama Y, Kashiwagi F, Terashi A: The role of bradykinin in mediating ischemic brain edema in rats. Stroke 24:571-575, 1993
83. Aoki M, Jonas RA, Nomura F, et al: Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg 58:146-153, 1994
84. Diaz PE, Fishbein MC, Davis MA, et al: Effect of the kallikrein inhibitor aprotinin on myocardial ischemic injury after coronary occlusion in the dog. Am J Cardiol 40:541-549, 1977
85. Gurevitch J, Paz Y, Barak J, et al: Role of protease inhibition in myocardial preservation following ischemia and reperfusion. J Cardiovasc Surg (Torino) 35:95-98, 1994
86. Levy JH, Ramsay JG, Murkin J: Aprotinin reduces the incidence of strokes following cardiac surgery. Circulation 94(suppl):1535, 1996
87. Smith PK, Muhlbaier LH: Aprotinin: Safe and effective only with the full-dose regimen. Ann Thorac Surg 62:1575-1577, 1996
88. Levy WJ: Monitoring of the electroencephalogram during cardiopulmonary bypass: Know when to say when. Anesthesiology 76:876-877, 1992
89. Bashein G, Nessly ML, Bledsoe SW, et al: Electroencephalography during surgery with cardiopulmonary bypass and hypothermia. Anesthesiology 76:878-891, 1992
90. Edmonds HL Jr, Griffiths LK, van der Laken J, et al: Quantitative electroencephalographic monitoring during myocardial revascularization predicts postoperative disorientation and improves outcome. J Thorac Cardiovasc Surg 103:555-563, 1992
91. Weyland A, Stephan H, Kazmaier S, et al: Flow velocity measurements as an index of cerebral blood flow: Validity of transcranial Doppler sonographic monitoring during cardiac surgery. Anesthesiology 81:1401-1410, 1994
92. 133Xe clearance cerebral blood flow during mild hypothermic cardiopulmonary bypass. J Clin Monit Comput 14:35-39, 1998
93. Grocott HP, Smith MS, Glower DD, Clements FM: Endovascular aortic balloon clamp malposition during minimally invasive cardiac surgery: Detection by transcranial Doppler monitoring. Anesthesiology 88:1396-1399, 1998
94. Stump DA, Rogers AT, Hammon JW, Newman SP: Cerebral emboli and cognitive outcome after cardiac surgery. J Cardiothorac Vasc Anesth 10:113-118, 1996
95. Trubiano P, Heyer EJ, Adams DC, et al: Jugular venous bulb oxyhemoglobin saturation during cardiac surgery: Accuracy and reliability using a continuous monitor. Anesth Analg 82:964-968, 1996
96. Robertson C: Desaturation episodes after severe head injury: Influence on outcome. Acta Neurochir 59 (suppl):98-101, 1993
97. Brown R, Wright G, Royston D: A comparison of two systems for assessing cerebral venous oxyhaemoglobin saturation during cardiopulmonary bypass in humans. Anaesthesia 48:697-700, 1993
98. Newman MF, Lowry E, Croughwell ND: Near-infrared spectroscopy (Invos 3100 A) and cognitive outcome after cardiac surgery. Anesth Analg 84:S111, 1997